岩藻黄素的药理作用及药物设计研究进展
x
请在关注微信后,向客服人员索取文件
篇名: | 岩藻黄素的药理作用及药物设计研究进展 |
TITLE: | Pharmacological effects and drug design research progress of fucoxanthin |
摘要: | 岩藻黄素是一种广泛存在于藻类、海洋浮游生物和水生贝壳等动植物中的类胡萝卜素,在医药领域具有巨大的开发潜力。本文综述了岩藻黄素在抗炎、抗氧化、抗肿瘤和抗肥胖方面的药理作用及其在药物设计方面的研究进展,发现其可通过激活AMP活化的蛋白质激酶等相关信号通路、调控炎症因子表达、改善菌群稳态等发挥抗炎、抗氧化作用,从而改善代谢相关脂肪性肝病、结肠炎等;可通过多靶点协同作用发挥选择性抗肿瘤效应;可通过调控肠道菌群等发挥抗肥胖作用;其特征性官能团(如羟基、环氧基团等)具有靶点选择性与可逆抑制活性,可作为优化模板指导新型药物设计开发,为突破传统药物设计局限提供了新思路。 |
ABSTRACT: | Fucoxanthin is a pigment found in plants and animals such as algae, marine plankton and aquatic shellfish, and holds significant potential for development in the pharmaceutical field. This review introduces the anti-inflammatory, antioxidant, anticancer, anti-obesity, and other pharmacological effects of fucoxanthin, as well as recent advances in drug design research. It was found that fucoxanthin can exert anti-inflammatory and antioxidant effects through mechanisms such as activating AMP- activated protein kinase related signaling pathways, regulating the expression of inflammatory factors, altering microbial stability, thereby improving conditions such as metabolic associated fatty liver disease and colitis. It can exert selective antitumor effects through multi-target synergistic actions; and it was also found that it can exert anti-obesity effects by regulating the intestinal microbiota. Its characteristic functional groups (such as hydroxyl and epoxy groups) possess target specificity and reversible inhibitory properties, making it a suitable template for guiding the design and development of novel drugs, thereby providing new insights for breaking through the limitations of traditional drug design. |
期刊: | 2025年第36卷第17期 |
作者: | 张育新;邓子洋;王灿;曾丹 |
AUTHORS: | ZHANG Yuxin,DENG Ziyang,WANG Can,ZENG Dan |
关键字: | 岩藻黄素;药理作用;药物设计;官能团;研究进展 |
KEYWORDS: | fucoxanthin; pharmacological effects; drug design; functional groups; research progress |
阅读数: | 10 次 |
本月下载数: | 0 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!